Global Artificial Intelligence (AI) in Precision Medicine Market Report and Forecast 2024-2032
Market Report I 2023-09-22 I 140 Pages I EMR Inc.
Global Artificial Intelligence (AI) in Precision Medicine Market Report and Forecast 2024-2032
Global Artificial Intelligence in Precision Medicine Market Outlook
The global artificial intelligence (AI) in precision medicine market size was valued USD 1.5 billion in 2023, driven by convergence of AI and healthcare, the availability of large-scale healthcare data, and the increasing demand for personalized treatment. The market size is anticipated to grow at a CAGR of 36% during the forecast period of 2024-2032 to achieve a value of USD 23.9 billion by 2032.
Artificial Intelligence in Precision Medicine: Introduction
Artificial Intelligence (AI) in precision medicine represents the intersection of advanced technologies and healthcare, with the aim of revolutionizing medical practices and improving patient outcomes. Precision medicine, also known as personalized medicine, involves tailoring medical treatment and interventions to the individual characteristics of each patient, such as their genetic makeup, lifestyle, and environmental factors. AI plays a pivotal role in the analysis and interpretation of complex patient data to provide highly personalized and effective healthcare solutions.
AI in precision medicine offers numerous benefits, including:
Personalized Treatment: Tailoring medical interventions to individual patients.
Improved Drug Development: Accelerating drug discovery and development.
Early Disease Detection: Enhancing the early detection of diseases.
Enhanced Patient Outcomes: Improving treatment effectiveness and patient outcomes.
More Efficient Clinical Trials: Optimizing the design and execution of clinical trials.
Key Trends in the Global Artificial Intelligence (AI) in Precision Medicine Market
Advancements in Genomic Analysis: AI-powered genomics analysis is becoming more sophisticated. AI algorithms can identify genetic variations, predict disease risks, and recommend targeted therapies based on an individual's genetic profile. This trend is particularly prominent in cancer genomics.
AI-Enhanced Diagnostic Imaging: AI is improving the accuracy and efficiency of diagnostic imaging in various medical fields. Radiology, pathology, and cardiology are benefiting from AI algorithms that can detect abnormalities, assist in diagnosis, and streamline image interpretation.
Drug Discovery and Development: AI is playing a significant role in drug discovery by accelerating target identification, lead compound screening, and drug repurposing. AI-driven drug discovery platforms are helping pharmaceutical companies bring new drugs to market more efficiently.
Clinical Decision Support Systems: AI-powered clinical decision support systems are becoming integral to healthcare. These systems analyze patient data, offer treatment recommendations, and provide real-time support to healthcare providers, leading to more informed decisions and improved patient outcomes.
Telemedicine and Remote Monitoring: The COVID-19 pandemic has accelerated the adoption of telemedicine and remote patient monitoring. AI-enabled telehealth platforms provide virtual consultations, remote monitoring of chronic conditions, and medication adherence support.
Global Artificial Intelligence (AI) in Precision Medicine Market Segmentation
The market can be categorised by type, components, therapeutic areas and region.
Market Breakup by Type
- Machine Learning
- Querying Method
- Deep Learning
- Context-Aware Processing
- Natural Language Processing
Market Breakup by Components
- Hardware
- Software
Market Breakup by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Artificial Intelligence (AI) in Precision Medicine Market Overview
The global artificial intelligence (AI) in precision medicine market is at the forefront of healthcare innovation, leveraging AI and data analytics to tailor medical treatment and interventions to the unique characteristics of individual patients. This market is characterized by rapid technological advancements, increasing adoption of AI in healthcare, and the growing demand for personalized medicine. The global AI in precision medicine market has been experiencing robust growth and is expected to continue expanding in the coming years. The market's growth is driven by the convergence of AI and healthcare, the availability of large-scale healthcare data, and the increasing demand for personalized treatment. AI in precision medicine is a global phenomenon, with healthcare organizations and institutions worldwide recognizing its potential to enhance patient care and drug development. the global AI in precision medicine market is poised for continued growth, driven by the convergence of AI and healthcare. It offers the promise of more personalized and effective treatments for patients, early disease detection, and accelerated drug development. As technology continues to advance and healthcare systems embrace AI-driven approaches, this market is expected to play a central role in shaping the future of healthcare and medicine.
Key Players in the Global Artificial Intelligence (AI) in Precision Medicine Market
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in global Artificial Intelligence (AI) in Precision Medicine Market are as follows:
- Novo Nordisk A/S
- GE Healthcare
- Intel Corporation
- NVIDIA Corporation
- Microsoft Corporation
- Alphabet Inc.
- IBM Corporation
- Enlitic Inc.
- AstraZeneca
- Sanofi
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
1Preface
1.1Objectives of the Study
1.2Key Assumptions
1.3Report Coverage - Key Segmentation and Scope
1.4Research Methodology
2Executive Summary
3Global Artificial Intelligence in Precision Medicine Market Overview
3.1Global Artificial Intelligence in Precision Medicine Market Historical Value (2017-2023)
3.2Global Artificial Intelligence in Precision Medicine Market Forecast Value (2024-2032)
4Global Artificial Intelligence in Precision Medicine Market Landscape
4.1Artificial Intelligence in Precision: Developers Landscape
4.1.1Analysis by Year of Establishment
4.1.2Analysis by Company Size
4.1.3Analysis by Region
4.2Artificial Intelligence in Precision: Product Landscape
4.2.1Analysis by Type
4.2.2Analysis by Components
4.2.3Analysis by Region
5Global Artificial Intelligence in Precision Medicine Market Dynamics
5.1Market Drivers and Constraints
5.2SWOT Analysis
5.3Porter's Five Forces Model
5.4Key Demand Indicators
5.5Key Price Indicators
5.6Industry Events, Initiatives, and Trends
5.7Value Chain Analysis
6Global Artificial Intelligence in Precision Medicine Market Segmentation
6.1Global Artificial Intelligence in Precision Medicine Market by Type
6.1.1Market Overview
6.1.2Machine Learning
6.1.3Querying Method
6.1.4Deep Learning
6.1.5Context-Aware Processing
6.1.6Natural Language Processing
6.2Global Artificial Intelligence in Precision Medicine Market by Components
6.2.1Market Overview
6.2.2Hardware
6.2.3Software
6.3Global Artificial Intelligence in Precision Medicine Market by Therapeutic Area
6.3.1Market Overview
6.3.2Oncology
6.3.3Neurology
6.3.4Cardiology
6.3.5Respiratory
6.3.6Others
6.4Global Artificial Intelligence in Precision Medicine Market by Region
6.4.1Market Overview
6.4.2North America
6.4.3Europe
6.4.4Asia Pacific
6.4.5Latin America
6.4.6Middle East and Africa
7North America Artificial Intelligence in Precision Medicine Market
7.1Market Share by Country
7.2United States of America
7.3Canada
8Europe Artificial Intelligence in Precision Medicine Market
8.1Market Share by Country
8.2United Kingdom
8.3Germany
8.4France
8.5Italy
8.6Others
9Asia Pacific Artificial Intelligence in Precision Medicine Market
9.1Market Share by Country
9.2China
9.3Japan
9.4India
9.5ASEAN
9.6Australia
9.7Others
10Latin America Artificial Intelligence in Precision Medicine Market
10.1Market Share by Country
10.2Brazil
10.3Argentina
10.4Mexico
10.5Others
11Middle East and Africa Artificial Intelligence in Precision Medicine Market
11.1Market Share by Country
11.2Saudi Arabia
11.3United Arab Emirates
11.4Nigeria
11.5South Africa
11.6Others
12Regulatory Framework
12.1Regulatory Overview
12.1.1US FDA
12.1.2EU EMA
12.1.3INDIA CDSCO
12.1.4JAPAN PMDA
12.1.5Others
13Patent Analysis
13.1Analysis by Type of Patent
13.2Analysis by Publication year
13.3Analysis by Issuing Authority
13.4Analysis by Patent Age
13.5Analysis by CPC Analysis
13.6Analysis by Patent Valuation
13.7Analysis by Key Players
14Grants Analysis
14.1Analysis by year
14.2Analysis by Amount Awarded
14.3Analysis by Issuing Authority
14.4Analysis by Grant Application
14.5Analysis by Funding Institute
14.6Analysis by NIH Departments
14.7Analysis by Recipient Organization
15Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2Analysis by Trial Status
15.3Analysis by Trial Phase
15.4Analysis by Therapeutic Area
15.5Analysis by Geography
16Funding and Investment Analysis
16.1Analysis by Funding Instances
16.2Analysis by Type of Funding
16.3Analysis by Funding Amount
16.4Analysis by Leading Players
16.5Analysis by Leading Investors
16.6Analysis by Geography
17Partnership and Collaborations Analysis
17.1Analysis by Partnership Instances
17.2Analysis by Type of Partnership
17.3Analysis by Leading Players
17.4Analysis by Geography
18Supplier Landscape
18.1Novo Nordisk A/S
18.1.1Financial Analysis
18.1.2Product Portfolio
18.1.3Demographic Reach and Achievements
18.1.4Mergers and Acquisitions
18.1.5Certifications
18.2GE Healthcare
18.2.1Financial Analysis
18.2.2Product Portfolio
18.2.3Demographic Reach and Achievements
18.2.4Mergers and Acquisitions
18.2.5Certifications
18.3Intel Corporation
18.3.1Financial Analysis
18.3.2Product Portfolio
18.3.3Demographic Reach and Achievements
18.3.4Mergers and Acquisitions
18.3.5Certifications
18.4NVIDIA Corporation
18.4.1Financial Analysis
18.4.2Product Portfolio
18.4.3Demographic Reach and Achievements
18.4.4Mergers and Acquisitions
18.4.5Certifications
18.5Microsoft Corporation
18.5.1Financial Analysis
18.5.2Product Portfolio
18.5.3Demographic Reach and Achievements
18.5.4Mergers and Acquisitions
18.5.5Certifications
18.6Alphabet Inc.
18.6.1Financial Analysis
18.6.2Product Portfolio
18.6.3Demographic Reach and Achievements
18.6.4Mergers and Acquisitions
18.6.5Certifications
18.7IBM Corporation
18.7.1Financial Analysis
18.7.2Product Portfolio
18.7.3Demographic Reach and Achievements
18.7.4Mergers and Acquisitions
18.7.5Certifications
18.8Enlitic Inc.
18.8.1Financial Analysis
18.8.2Product Portfolio
18.8.3Demographic Reach and Achievements
18.8.4Mergers and Acquisitions
18.8.5Certifications
18.9AstraZeneca
18.9.1Financial Analysis
18.9.2Product Portfolio
18.9.3Demographic Reach and Achievements
18.9.4Mergers and Acquisitions
18.9.5Certifications
18.10Sanofi
18.10.1Financial Analysis
18.10.2Product Portfolio
18.10.3Demographic Reach and Achievements
18.10.4Mergers and Acquisitions
18.10.5Certifications
19Key Opinion Leaders (KOL) Insights (Additional Insight)
20Company Competitiveness Analysis (Additional Insight)
20.1Very Small Companies
20.2Small Companies
20.3Mid-Sized Companies
20.4Large Companies
20.5Very Large Companies
21Payment Methods (Additional Insight)
21.1Government Funded
21.2Private Insurance
21.3Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.